Related Experiment Video
Updated: Jul 5, 2026
07:45
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
Basal-like breast cancer: a critical review
Emad A Rakha1, Jorge S Reis-Filho, Ian O Ellis
1Department of Histopathology, Nottingham City Hospital National Health Service (NHS) Trust, UK.
Summary
Basal-like breast cancer, often triple-negative, shows aggressive behavior and poor prognosis. Consistent identification and classification are crucial for developing effective treatment strategies for this subtype.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Gene expression profiling reveals distinct breast cancer subtypes.
- Basal-like tumors share characteristics with BRCA1-associated cancers.
- These tumors often present as triple-negative, lacking hormone receptors and HER-2.
Purpose of the Study:
- To review the definition and clinical significance of basal-like breast cancer.
- To address the heterogeneity and classification challenges of this subtype.
- To highlight the need for standardized identification and treatment strategies.
Main Methods:
- Review of existing literature on basal-like breast cancer.
- Analysis of gene expression data and clinical outcomes.
- Discussion of morphologic, genetic, and immunophenotypic features.
Main Results:
- Basal-like breast cancer is associated with aggressive behavior and poor prognosis.
- Lack of a consensus definition complicates routine clinical identification.
- Tumors exhibit distinctive but heterogeneous features.
Conclusions:
- Standardized definitions and classification systems are needed for basal-like breast cancer.
- Further research is required to develop targeted therapies for this subtype.
- Understanding basal-like breast cancer's heterogeneity is key to improving patient outcomes.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...